omega healthcare investors inc. - OHI
OHI
Close Chg Chg %
37.49 0.58 1.53%
Closed Market
38.07
+0.58 (1.53%)
Volume: 1.41M
Last Updated:
Mar 28, 2025, 3:59 PM EDT
Company Overview: omega healthcare investors inc. - OHI
OHI Key Data
| Open $37.75 | Day Range 37.45 - 38.16 |
| 52 Week Range 29.66 - 44.42 | Market Cap $10.57B |
| Shares Outstanding 281.84M | Public Float 281.25M |
| Beta 0.99 | Rev. Per Employee N/A |
| P/E Ratio 25.11 | EPS $1.57 |
| Yield 710.50% | Dividend $0.67 |
| EX-DIVIDEND DATE Feb 10, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.43M |
OHI Performance
| 1 Week | 1.90% | ||
| 1 Month | 3.37% | ||
| 3 Months | 0.61% | ||
| 1 Year | 20.24% | ||
| 5 Years | 58.01% |
OHI Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
16
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 41.214 | |
| Number of Ratings | 16 | Current Quarters Estimate | 0.445 | |
| FY Report Date | 03 / 2025 | Current Year's Estimate | 1.673 | |
| Last Quarter’s Earnings | 0.41 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.55 | Next Fiscal Year Estimate | 1.768 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 5 | 7 | 7 |
| Mean Estimate | 0.45 | 0.44 | 1.67 | 1.77 |
| High Estimates | 0.46 | 0.45 | 1.80 | 1.93 |
| Low Estimate | 0.42 | 0.43 | 1.24 | 1.27 |
| Coefficient of Variance | 4.24 | 2.60 | 11.74 | 12.64 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 6 | 6 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 10 | 9 | 9 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Omega Healthcare Investors Inc. - OHI
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Omega Healthcare Investors Inc. - OHI
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jan 6, 2025 | Neal A. Ballew CHIEF ACCOUNTING OFFICER | 3,636 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $32.18 per share | 117,006.48 |
| Jan 6, 2025 | Neal A. Ballew CHIEF ACCOUNTING OFFICER | 3,626 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $37.85 per share | 137,244.10 |
| Jun 26, 2024 | Robert O. Stephenson CHIEF FINANCIAL OFFICER | 235,618 | Bona fide gift | 0.00 |
| Jun 12, 2024 | Burke W. Whitman Director | 39,765 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $32.57 per share | 1,295,146.05 |
| Jun 12, 2024 | Kapila Kapur Anand Director | 33,772 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 12, 2024 | Kevin J. Jacobs Director | 33,696 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $32.57 per share | 1,097,478.72 |
| Jun 12, 2024 | Lisa C. Egbuonu-Davis Director | 18,118 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $32.57 per share | 590,103.26 |
| Apr 19, 2024 | Gail D. Makode CHIEF LEGAL OFFICER | 1,142 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |